UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000019455
Receipt number R000022487
Scientific Title Study of the Influenza vaccine immune response using PMMA dialyzer.
Date of disclosure of the study information 2015/10/26
Last modified on 2018/04/23 16:56:51

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Study of the Influenza vaccine immune response using PMMA dialyzer.

Acronym

Influenza vaccine effectiveness in using PMMA dialyzer

Scientific Title

Study of the Influenza vaccine immune response using PMMA dialyzer.

Scientific Title:Acronym

Influenza vaccine effectiveness in using PMMA dialyzer

Region

Japan


Condition

Condition

End-stage renal disease requiring hemodialysis

Classification by specialty

Medicine in general Endocrinology and Metabolism Nephrology
Urology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

Acquisition influenza immunization

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Improvement of immune responsiveness at 6 months after conversiton to PMMA dialyzer

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Historical

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Treatment

Type of intervention

Device,equipment

Interventions/Control_1

Dialyzers will be chnaged to the PMMA dialyzers, on patients who was made immunity to influenza vaccination.

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

The patients whose age is over 20 years at the time of enrollment in this study.

Key exclusion criteria

A patient who is judged as the inadequate subject of this study by the doctor.

Target sample size

120


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Tadashi Tomo

Organization

Oita university hospital

Division name

Blood purfication center

Zip code


Address

Idai-gaoka,1-1, Hasama-machi, Yufu-city, Oita,Japan

TEL

097-586-6741

Email

tomo@oita-u.ac.jp


Public contact

Name of contact person

1st name
Middle name
Last name Tadashi Tomo

Organization

Oita university hospital

Division name

Blood purfication center

Zip code


Address

Idai-gaoka,1-1, Hasama-machi, Yufu-city, Oita,Japan

TEL

097-586-6741

Homepage URL


Email

tomo@oita-u.ac.jp


Sponsor or person

Institute

Oita University Hospital
Blood purification center

Institute

Department

Personal name



Funding Source

Organization

Toray Industories Inc.

Organization

Division

Category of Funding Organization

Profit organization

Nationality of Funding Organization



Other related organizations

Co-sponsor

Oita Naika Clinic
Matsuyama Iin
Oita Nakamura Hospital
Suwanomoriori Hospital

Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2015 Year 10 Month 26 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2015 Year 10 Month 22 Day

Date of IRB


Anticipated trial start date

2015 Year 10 Month 26 Day

Last follow-up date

2017 Year 05 Month 31 Day

Date of closure to data entry

2017 Year 12 Month 31 Day

Date trial data considered complete

2018 Year 01 Month 09 Day

Date analysis concluded

2018 Year 01 Month 09 Day


Other

Other related information



Management information

Registered date

2015 Year 10 Month 22 Day

Last modified on

2018 Year 04 Month 23 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000022487


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name